NCT00590993已完成不适用
Magnetic Resonance Imaging and Spectroscopy of the Prostate
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 1,005
- 试验地点
- 1
- 主要终点
- Determine added value in combining MRSI and MRI in prostate cancer treatment
研究概览
简要总结
Past studies have shown that MRI is useful for staging prostate cancer. This study will use magnetic resonance spectroscopic imaging (MRSI) to obtain more information. MRSIs with MRIs help doctors locate prostate cancer and determine the extent of tumor before deciding on treatment. This study looks at structural and chemical properties of prostates in prostate cancer patients before and after treatment.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- Male
- 接受健康志愿者
- 否
入选标准
- •prostate cancer patients willing to undergo a MRI and MRSI exam
排除标准
- •patients with prostate cancer and bone or lymph node metastasis
- •patients who can not have an MRI exam
结局指标
主要结局
Determine added value in combining MRSI and MRI in prostate cancer treatment
时间窗: 3 hours
次要结局
未报告次要终点
研究者
研究点 (1)
Loading locations...
相似试验
进行中（未招募）
不适用
Prospective Clinical Safety and Efficacy Study of Lesion-targeted MRI-TULSA for Localized Prostate CancerLocalized Prostate CancerNCT03814252Turku University Hospital62
已完成
不适用
Clinico-pathologic Correlative Study of 3T Magnetic Resonance Spectroscopy in the Localization of Prostate CancerProstate CancerNCT00310479AHS Cancer Control Alberta16
Unknown
不适用
MRI in Diagnosing Prostate CancerProstate CancerNCT01292291University College London Hospitals714
已完成
不适用
Magnetic Resonance Imaging to Evaluate Prostate CancerProstatic NeoplasmsNCT00182624National Institutes of Health Clinical Center (CC)80
已完成
不适用
MRI/MRSI in Risk Assessment of Prostate Cancer PatientsProstate CancerNCT00582543Memorial Sloan Kettering Cancer Center357